Good morning ... Situational awareness: Ronny Jackson's nomination to lead the Department of Veterans Affairs continues to implode.
More than half of voters in Arizona, Nevada and Tennessee want Congress to modify the Affordable Care Act, while less than a third want it to be completely repealed and only 6% think Congress should “let it fail.”
Why it matters: Arizona and Nevada are seen as the states where Democrats have the best chance in November to take Senate seats currently held by Republicans, and Tennessee is working its way up the list. One of Democrats' most unifying and effective messages this cycle is health care, and they'll be sure to campaign hard against the GOP's repeal effort in these states.
There's a pump, which can be implanted in cancer patients' abdomens, that sends high doses of chemotherapy straight to patients' livers, adding years to the average patient's lifespan. At least, there is for now. Its manufacturer, Johnson & Johnson, plans to quit making the device, The New York Times reports.
The big picture: The Codman pump is a medical device, not a drug, but it still raises some of the same issues that could confront the next generation of highly personalized treatments — products that work better for a smaller number of people, probably at a higher price.
The details, per the NYT:
My colleague Bob Herman is here to catch you up on some of the most important nuggets from the health care industry’s Q1 earnings spree this week.
Teens vaping at a 2017 Vapexpo in Russia. Photo: Sergei Konkov/TASS via Getty Images
The e-cigarette manufacturer Juul says it’s on the FDA’s side in the campaign against youth access to e-cigarettes.
The latest: The FDA earlier this week announced a multi-pronged crackdown on e-cigarettes — specifically the ones most popular among teens, which includes Juul.
What's next: The company will begin running a series of full-page ads today in Washington, New York and Boston, casting itself as an ally of the FDA and a positive force for change among adult smokers.
Bob has tallied up the 2017 pay packages of 30 health care CEOs so far this proxy season, including the five newly released figures below, and those executives have made a combined $976 million — or double the annual budget of the National Institute on Alcohol Abuse and Alcoholism.
PRA Health Sciences
What we're watching today: A dozen health care companies report earnings today, including pharma giants AbbVie and Bristol-Myers Squibb and device companies Stryker and Zimmer Biomet.
Senate homeland security panel hearing on HHS' efforts to combat human trafficking. House Ways and Means Committee hearing on innovation in health care.